Search

Home > New FDA Approvals > 155 - cannabidiol of lennoxgastault syndrome; clearance of Access hsTnI assay; FRESCA CPAP system; FDA meeting announcement for Nutrition Innovation Strategy
Podcast: New FDA Approvals
Episode:

155 - cannabidiol of lennoxgastault syndrome; clearance of Access hsTnI assay; FRESCA CPAP system; FDA meeting announcement for Nutrition Innovation Strategy
Category: Science & Medicine
Duration: 00:09:47
Publish Date: 2018-06-28 07:21:50
Description:

June 28, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

0.33 FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm611046.htm https://www.prnewswire.com/news-releases/first-prescription-formulation-of-cannabidiol-cbd-approved-for-lennox-gastaut-syndrome-300672005.html 

2:43 Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay https://www.prnewswire.com/news-releases/beckman-coulter-diagnostics-receives-us-fda-510k-clearance-for-high--sensitivity-access-hstni-assay-300673012.html

5:20 FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea https://www.prnewswire.com/news-releases/fda-authorizes-fresca-medical-to-market-new-positive-airway-pressure-delivery-system-to-treat-sleep-apnea-300671067.html 

6:39 Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to advance health through improvements in nutrition under the agency’s Nutrition Innovation Strategy https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm611784.htm

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0